Drug Design 2013 will address the latest developments in computational and experimental approaches to fragment- and ligand-based drug design. The conference is aimed at bringing together biologists, chemists and computational scientists from academia and industry to discuss the latest developments and breakthroughs in cutting-edge in silico and experimental drug design approaches…visit event website